Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/aor.14024 http://scihub22266oqcxt.onion/10.1111/aor.14024 34152629!8444787!34152629     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Artif+Organs 2021 ; 45 (11): 1338-1347 Nephropedia Template TP {{tp|p=34152629|t=2021. Blood purification with CytoSorb in critically ill COVID-19 patients: A case series of 26 patients |pdf=|usr=}}{{34152629}} gab.com Text Blood purification with CytoSorb in critically ill COVID-19 patients: A case series of 26 patients JO: Artif Organs http://www.kidney.de/pget.php?&tw=1&pmid=34152629 #FOAvip Severe forms of the coronavirus disease 2019 (COVID-19) can progress to sepsis-like complications accompanied by "cytokine storm" for which the most effective treatment has not yet been established. Our study describes the results of CytoSorb hemoadsorption in COVID-19 patients treated on the intensive care unit (ICU). In this retrospective study, 26 patients with COVID-19 and acute respiratory distress syndrome (ARDS) were treated with hemoadsorption therapy. Pre-, and post-treatment values (clinical and laboratory) were compared. Data are expressed as mean (confidence intervals, CI), or median [interquartile ranges, IQR], as appropriate. Patients received 2 hemoadsorption treatments. This resulted in a significant decrease in norepinephrine requirements, and inflammatory marker plasma concentrations (procalcitonin, C-reactive protein, ferritin) when comparing pre versus post treatment levels. The PaO(2) /FiO(2) and overall organ function (ie, Sequential Organ Failure Assessment-SOFA score) also improved significantly. Patients stayed on the ICU for 9 days and 21 of them survived. To the best of our knowledge, this is one of the largest case series to date reporting early experiences on extracorporeal hemoadsorption therapy in SARS-CoV-2 positive patients with hyperinflammation and moderate ARDS. Treatment proved to be effective, technically feasible and well-tolerated. Twit Text FOAVip Blood purification with CytoSorb in critically ill COVID-19 patients: A case series of 26 patients ????Artif Organs http://www.kidney.de/pget.php?&tw=1&pmid=34152629 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34152629 #FOAvip English Wikipedia <ref>{{Cite pmid|34152629}}</ref> Blood purification with CytoSorb in critically ill COVID-19 patients: A case series of 26 patients #MMPMID34152629 Nassiri AA; Hakemi MS; Miri MM; Shahrami R; Koomleh AA; Sabaghian T Artif Organs 2021[Nov]; 45 (11): 1338-1347 PMID34152629show ga Severe forms of the coronavirus disease 2019 (COVID-19) can progress to sepsis-like complications accompanied by "cytokine storm" for which the most effective treatment has not yet been established. Our study describes the results of CytoSorb hemoadsorption in COVID-19 patients treated on the intensive care unit (ICU). In this retrospective study, 26 patients with COVID-19 and acute respiratory distress syndrome (ARDS) were treated with hemoadsorption therapy. Pre-, and post-treatment values (clinical and laboratory) were compared. Data are expressed as mean (confidence intervals, CI), or median [interquartile ranges, IQR], as appropriate. Patients received 2 hemoadsorption treatments. This resulted in a significant decrease in norepinephrine requirements, and inflammatory marker plasma concentrations (procalcitonin, C-reactive protein, ferritin) when comparing pre versus post treatment levels. The PaO(2) /FiO(2) and overall organ function (ie, Sequential Organ Failure Assessment-SOFA score) also improved significantly. Patients stayed on the ICU for 9 days and 21 of them survived. To the best of our knowledge, this is one of the largest case series to date reporting early experiences on extracorporeal hemoadsorption therapy in SARS-CoV-2 positive patients with hyperinflammation and moderate ARDS. Treatment proved to be effective, technically feasible and well-tolerated. |*Hemadsorption[MESH] |Biomarkers/blood[MESH] |COVID-19/mortality/*therapy[MESH] |Comorbidity[MESH] |Critical Illness[MESH] |Cytokine Release Syndrome/*therapy/virology[MESH] |Female[MESH] |Hospital Mortality[MESH] |Humans[MESH] |Intensive Care Units[MESH] |Iran[MESH] |Male[MESH] |Middle Aged[MESH] |Organ Dysfunction Scores[MESH] |Pneumonia, Viral/mortality/*therapy/virology[MESH] |Retrospective Studies[MESH] |SARS-CoV-2[MESH]Blood purification with CytoSorb in critically ill COVID-19 patients: (epmc).pdf DeepDyve Pubget Overpricing